Sanofi is paying Regeneron up to $8 billion to expand their immunology alliance
What happened
Regeneron will receive $1 billion upfront, with up to $7 billion more in milestones, to co-develop four next-generation antibody drug candidates
Summary assembled by rule from the sources below